Evaluation of the Effects of Cornus mas L. Fruit Extract on Glycemic Control and Insulin Level in Type 2 Diabetic Adult Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial
Background. The plant Cornus mas L. (cornelian cherry) is traditionally used as an antidiabetic supplement; however, there is no related clinical trial. In this study, we evaluated the effects of the fruit extract of this plant on biomarkers of glycemic control in adult patients with type 2 diabetes...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2015/740954 |
id |
doaj-fc7655d2f4b64f409b3217cd4ed3b9b8 |
---|---|
record_format |
Article |
spelling |
doaj-fc7655d2f4b64f409b3217cd4ed3b9b82020-11-25T00:14:47ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882015-01-01201510.1155/2015/740954740954Evaluation of the Effects of Cornus mas L. Fruit Extract on Glycemic Control and Insulin Level in Type 2 Diabetic Adult Patients: A Randomized Double-Blind Placebo-Controlled Clinical TrialRasool Soltani0Abdollah Gorji1Sedigheh Asgary2Nizal Sarrafzadegan3Mansour Siavash4Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, IranIsfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IranIsfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IranIsfahan Endocrine & Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, IranBackground. The plant Cornus mas L. (cornelian cherry) is traditionally used as an antidiabetic supplement; however, there is no related clinical trial. In this study, we evaluated the effects of the fruit extract of this plant on biomarkers of glycemic control in adult patients with type 2 diabetes. Methods. Sixty patients with type 2 diabetes were randomly assigned to two groups to receive either the extract or placebo capsules (2 capsules twice daily) for 6 weeks. Each drug capsule contained 150 mg of anthocyanins. Fasting plasma levels of glucose, insulin, HgbA1C, and triglyceride as well as 2-hour postprandial glucose level (2Hpp) were measured before and after the intervention and finally the mean values were compared between groups. Results. After 6 weeks of intervention, significant increase in insulin level (1.13 ± 1.90 versus −0.643 ± 1.82, P<0.05) as well as decrease in HgbA1C (−0.24 ± 0.429 versus 0.023 ± 0.225, P<0.05) and TG (−23.66 ± 55.40 versus 2.83 ± 15.71, P<0.05) levels was observed in drug group compared to placebo. Conclusion. Daily consumption of the fruit extract of Cornus mas L. improves glycemic control by increasing insulin level and reduces TG serum level in type 2 diabetic adult patients.http://dx.doi.org/10.1155/2015/740954 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rasool Soltani Abdollah Gorji Sedigheh Asgary Nizal Sarrafzadegan Mansour Siavash |
spellingShingle |
Rasool Soltani Abdollah Gorji Sedigheh Asgary Nizal Sarrafzadegan Mansour Siavash Evaluation of the Effects of Cornus mas L. Fruit Extract on Glycemic Control and Insulin Level in Type 2 Diabetic Adult Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial Evidence-Based Complementary and Alternative Medicine |
author_facet |
Rasool Soltani Abdollah Gorji Sedigheh Asgary Nizal Sarrafzadegan Mansour Siavash |
author_sort |
Rasool Soltani |
title |
Evaluation of the Effects of Cornus mas L. Fruit Extract on Glycemic Control and Insulin Level in Type 2 Diabetic Adult Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial |
title_short |
Evaluation of the Effects of Cornus mas L. Fruit Extract on Glycemic Control and Insulin Level in Type 2 Diabetic Adult Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial |
title_full |
Evaluation of the Effects of Cornus mas L. Fruit Extract on Glycemic Control and Insulin Level in Type 2 Diabetic Adult Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial |
title_fullStr |
Evaluation of the Effects of Cornus mas L. Fruit Extract on Glycemic Control and Insulin Level in Type 2 Diabetic Adult Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial |
title_full_unstemmed |
Evaluation of the Effects of Cornus mas L. Fruit Extract on Glycemic Control and Insulin Level in Type 2 Diabetic Adult Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial |
title_sort |
evaluation of the effects of cornus mas l. fruit extract on glycemic control and insulin level in type 2 diabetic adult patients: a randomized double-blind placebo-controlled clinical trial |
publisher |
Hindawi Limited |
series |
Evidence-Based Complementary and Alternative Medicine |
issn |
1741-427X 1741-4288 |
publishDate |
2015-01-01 |
description |
Background. The plant Cornus mas L. (cornelian cherry) is traditionally used as an antidiabetic supplement; however, there is no related clinical trial. In this study, we evaluated the effects of the fruit extract of this plant on biomarkers of glycemic control in adult patients with type 2 diabetes. Methods. Sixty patients with type 2 diabetes were randomly assigned to two groups to receive either the extract or placebo capsules (2 capsules twice daily) for 6 weeks. Each drug capsule contained 150 mg of anthocyanins. Fasting plasma levels of glucose, insulin, HgbA1C, and triglyceride as well as 2-hour postprandial glucose level (2Hpp) were measured before and after the intervention and finally the mean values were compared between groups. Results. After 6 weeks of intervention, significant increase in insulin level (1.13 ± 1.90 versus −0.643 ± 1.82, P<0.05) as well as decrease in HgbA1C (−0.24 ± 0.429 versus 0.023 ± 0.225, P<0.05) and TG (−23.66 ± 55.40 versus 2.83 ± 15.71, P<0.05) levels was observed in drug group compared to placebo. Conclusion. Daily consumption of the fruit extract of Cornus mas L. improves glycemic control by increasing insulin level and reduces TG serum level in type 2 diabetic adult patients. |
url |
http://dx.doi.org/10.1155/2015/740954 |
work_keys_str_mv |
AT rasoolsoltani evaluationoftheeffectsofcornusmaslfruitextractonglycemiccontrolandinsulinlevelintype2diabeticadultpatientsarandomizeddoubleblindplacebocontrolledclinicaltrial AT abdollahgorji evaluationoftheeffectsofcornusmaslfruitextractonglycemiccontrolandinsulinlevelintype2diabeticadultpatientsarandomizeddoubleblindplacebocontrolledclinicaltrial AT sedighehasgary evaluationoftheeffectsofcornusmaslfruitextractonglycemiccontrolandinsulinlevelintype2diabeticadultpatientsarandomizeddoubleblindplacebocontrolledclinicaltrial AT nizalsarrafzadegan evaluationoftheeffectsofcornusmaslfruitextractonglycemiccontrolandinsulinlevelintype2diabeticadultpatientsarandomizeddoubleblindplacebocontrolledclinicaltrial AT mansoursiavash evaluationoftheeffectsofcornusmaslfruitextractonglycemiccontrolandinsulinlevelintype2diabeticadultpatientsarandomizeddoubleblindplacebocontrolledclinicaltrial |
_version_ |
1725388553832103936 |